secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2026-06-17T12:01:14+00:00
Accession:  0001728117-26-000054
Event type: debt
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio completes exchange of 94.5% of 2027 notes; $18.9M remain outstanding
--------------------------------------------------------------------------------

- $181.1M principal (94.5%) of 5% 2027 notes tendered; exchanged for new 7.5% 2030 notes and equity.
- Company lowered tender condition from 98% to 90.5% after sufficient early participation by June 2.
- Early settlement occurred June 4; supplemental indenture eliminated restrictive covenants.
- No additional notes tendered after early date; $18.9M of existing notes remain outstanding.
- New 7.5% secured first lien notes due 2030, plus up to 317.6M shares or prefunded warrants issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000054/0001728117-26-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000054/goss-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001728117-26-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer